Influence of hemoglobin vesicles, cellular‐type artificial oxygen carriers, on human umbilical cord blood hematopoietic progenitor cellsin vitro
- 6 February 2008
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 88A (1) , 34-42
Abstract
Hemoglobin vesicles (HbVs), liposomal oxygen carriers containing human hemoglobin, are candidates for development as clinically useful blood substitutes. Although HbVs are shown to distribute transiently into the bone marrow in animal models, the influence of HbVs on human hematopoietic stem/progenitor cells has not yet been studied. Therefore, we investigated the influence of HbVs at a concentration of up to 3 vol/vol % on the clonogenic activity (in semisolid culture) and proliferative activity (in liquid culture) of human hematopoietic progenitor cells derived from umbilical cord blood (CB)in vitro. Continuous exposure of CB mononuclear cells to HbVs tended to decrease the number and size of mature‐committed colonies and most notably reduced the number of colonies of high‐proliferative potential colony‐forming cells (HPP‐CFC). In contrast, exposure to HbVs for 20 h or 3 days, which is more relevant to the clinical setting, had no effect on the number of mature‐committed colonies and only modestly decreased the number of HPP‐CFC. Continuous exposure (10 days) to HbVs significantly suppressed the cellular proliferation and differentiation of both the erythroid and myeloid lineages in liquid culture. Again, short exposure (20 h or 3 days) did not affect these parameters. Thus, our results show that HbVs, under conditions relevant to the clinical setting, have no adverse effect on human CB hematopoietic progenitor activityin vitro. © 2008 Wiley Periodicals, Inc. J Biomed Mater Res, 2009Keywords
This publication has 23 references indexed in Scilit:
- Effects of Hemoglobin Vesicles, a Liposomal Artificial Oxygen Carrier, on Hematological Responses, Complement and Anaphylactic Reactions in RatsArtificial Cells, Blood Substitutes, and Biotechnology, 2007
- Oxygen transport by low and normal oxygen affinity hemoglobin vesicles in extreme hemodilutionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Hemorrhagic Shock Resuscitation With an Artificial Oxygen Carrier, Hemoglobin Vesicle, Maintains Intestinal Perfusion and Suppresses the Increase in Plasma Tumor Necrosis Factor-αASAIO Journal, 2004
- Hemoglobin‐based Red Blood Cell SubstitutesArtificial Organs, 2004
- Hemoglobin-vesicles suspended in recombinant human serum albumin for resuscitation from hemorrhagic shock in anesthetized rats*Critical Care Medicine, 2004
- Detection of lipopolysaccharide in hemoglobin‐vesicles by Limulus amebocyte lysate test with kinetic–turbidimetric gel clotting analysis and pretreatment of surfactantJournal of Pharmaceutical Sciences, 2004
- Effective Encapsulation of Proteins into Size‐Controlled Phospholipid Vesicles Using Freeze‐Thawing and ExtrusionBiotechnology Progress, 2003
- Hemoglobin-Vesicles as Oxygen CarriersThe American Journal of Pathology, 2001
- EFFECTS OF POLY(ETHYLENEGLYCOL)-MODIFIED HEMOGLOBIN VESICLES ONN-FORMYL-METHIONYL-LEUCYL-PHENYLALANINE-INDUCED RESPONSES OF POLYMORPHONUCLEAR NEUTROPHILSIN VITROArtificial Cells, Blood Substitutes, and Biotechnology, 2001
- Effect of recombinant human hemoglobin on human bone marrow progenitor cells: protection and reversal of 3′ -azido-3′ -deoxythymidine-induced toxicityToxicology Letters, 1996